NEW YORK, Feb. 16 (GenomeWeb News) - Incaps and Bioanalytical Systems have signed an alliance to provide complementary services to clients, BASi announced today.
Under the deal, BASi will rely on INCAPS to service clients' needs for instrumentation, informatics, and statistical analysis, the company said.
The partnership will mean "one-stop shopping for large and small-molecule work," said Incaps CEO James Ludwig.
Financial details were not provided.
BASi is a drug-to-market contract research company located in West Lafayette, In.
Incaps, which offers protein analysis, proteomics, technology validation and biomarker collaboration, is located in Indianapolis.